Epigenomics Ag Stock Fundamentals
| EPGNF Stock | USD 0.50 2.00 80.00% |
Epigenomics AG fundamentals help investors to digest information that contributes to Epigenomics' financial success or failures. It also enables traders to predict the movement of Epigenomics Pink Sheet. The fundamental analysis module provides a way to measure Epigenomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epigenomics pink sheet.
Epigenomics |
Epigenomics AG Company Current Valuation Analysis
Epigenomics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Epigenomics Current Valuation | (9.71 M) |
Most of Epigenomics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Epigenomics AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Epigenomics AG has a Current Valuation of (9.71 Million). This is 100.07% lower than that of the Healthcare sector and 100.12% lower than that of the Diagnostics & Research industry. The current valuation for all United States stocks is 100.06% higher than that of the company.
Epigenomics AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Epigenomics's current stock value. Our valuation model uses many indicators to compare Epigenomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Epigenomics competition to find correlations between indicators driving Epigenomics's intrinsic value. More Info.Epigenomics AG is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Epigenomics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Epigenomics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Epigenomics' earnings, one of the primary drivers of an investment's value.Epigenomics Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epigenomics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Epigenomics could also be used in its relative valuation, which is a method of valuing Epigenomics by comparing valuation metrics of similar companies.Epigenomics is currently under evaluation in current valuation category among related companies.
Epigenomics Fundamentals
| Return On Equity | -0.38 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (15.90) % | |||
| Current Valuation | (9.71 M) | |||
| Shares Outstanding | 4.09 M | |||
| Shares Owned By Insiders | 35.00 % | |||
| Shares Owned By Institutions | 4.86 % | |||
| Price To Earning | (8.47) X | |||
| Price To Book | 0.39 X | |||
| Price To Sales | 10.64 X | |||
| Revenue | 6.2 M | |||
| Gross Profit | 6.07 M | |||
| EBITDA | (1.94 M) | |||
| Net Income | (2.43 M) | |||
| Cash And Equivalents | 15.77 M | |||
| Cash Per Share | 0.96 X | |||
| Total Debt | 966 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 3.88 X | |||
| Book Value Per Share | 3.41 X | |||
| Cash Flow From Operations | (4.15 M) | |||
| Earnings Per Share | (0.30) X | |||
| Target Price | 8.59 | |||
| Number Of Employees | 36 | |||
| Beta | 1.08 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 24.66 M | |||
| Retained Earnings | (62 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 10 M | |||
| Current Liabilities | 5 M | |||
| Z Score | 0.8 | |||
| Net Asset | 24.66 M |
About Epigenomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epigenomics AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epigenomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epigenomics AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.
Pair Trading with Epigenomics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Epigenomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epigenomics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Epigenomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Epigenomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Epigenomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Epigenomics AG to buy it.
The correlation of Epigenomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Epigenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Epigenomics AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Epigenomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epigenomics AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Epigenomics Pink Sheet analysis
When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |